LGP 2.13% 11.5¢ little green pharma ltd

Cannabis cultivators Comparisons, page-7

  1. 5 Posts.
    lightbulb Created with Sketch. 1
    LGP have complete supply chain control from cultivating, testing, processing, distribution and retail/patient, as well as R&D operations, clinical trials, genetic programs and the like.

    To compare or call them just a 'cultivator' sort of undermines and undervalues the offering they have. They are already good to go with GMP certification which is going to kick in as mandatory later in the year while a lot of other companies will be chasing their tails trying to get certified or working a way around it.

    The edge they have is that they don't have to rely on any external parties in order to bring their products to market, which might be an issue for some as the GMP cert hits, and suddenly "Australian" importers have to invest in making sure they comply which will probably see an increase in overheads in the 'frugal' companies.
 
watchlist Created with Sketch. Add LGP (ASX) to my watchlist
(20min delay)
Last
11.5¢
Change
-0.003(2.13%)
Mkt cap ! $34.83M
Open High Low Value Volume
12.0¢ 12.0¢ 11.5¢ $31.66K 274.0K

Buyers (Bids)

No. Vol. Price($)
1 135447 11.5¢
 

Sellers (Offers)

Price($) Vol. No.
12.0¢ 31600 1
View Market Depth
Last trade - 15.50pm 08/11/2024 (20 minute delay) ?
LGP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.